Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/14/2013DE112012000807T5 Pyrrolo[2,1-c][1,4]naphthodiazepin-verknüpfte Piperazinverbindungen und Verfahren zu deren Herstellung Pyrrolo [2,1-c] [1,4] naphthodiazepine-linked piperazine compounds and process for their preparation
11/14/2013DE102012103717A1 Use of phosphonoformic acid or its hydrate, ester and/or salt for treating tumor diseases and/or age-related macular degeneration, where tumor diseases are fibroblast growth factor-2 overexpressing tumors consisting of e.g. melanoma
11/14/2013DE102012011447A1 Use of pantothenol or its ester and/or pantothenic acid or its salts together and/or in combination with imidazoline-based alpha-sympathomimetic activity or its salts, used to treat rhinitis and/or to prepare drug for treating rhinitis
11/14/2013DE102012009057A1 Rotational pessary made from a polymer comprises an active substance against premature births
11/14/2013CA2873138A1 Compositions and methods for the treatment of local pain
11/14/2013CA2873087A1 Compositions and methods for the treatment of hyperglycemia
11/14/2013CA2873016A1 Compositions and methods for the treatment of epilepsy
11/14/2013CA2872976A1 Compositions and methods for the treatment of neurological disorders
11/13/2013EP2662453A2 Detection and treatment of schizophrenia
11/13/2013EP2662446A2 RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
11/13/2013EP2662441A1 Method for the in vitro maturation of dendritic cells
11/13/2013EP2662382A1 Sterol derivatives, method for preparing same, pharmaceutical compositions containing same and use thereof for the treatment of multiple glioblastomas
11/13/2013EP2662374A1 Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7 -diaza-spiro[4.5]decan-2-one and preparation process therefor
11/13/2013EP2662373A1 Salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
11/13/2013EP2662372A1 Alpha-carbolines for the treatment of cancer
11/13/2013EP2662371A1 (R)-Nifuratel and synthesis of (R) and (S)-Nifuratel
11/13/2013EP2662367A1 Novel indole or indazole derivative or salt thereof
11/13/2013EP2662366A1 Novel triazinedione derivatives as GABA-B receptor modulators
11/13/2013EP2662358A1 Catecholamine derivatives and prodrugs thereof
11/13/2013EP2662357A1 Novel bicyclic compound or salt thereof
11/13/2013EP2662117A1 Herpes Simplex Virus for the treatment of liver cancer
11/13/2013EP2662093A1 Tobramycin formulation
11/13/2013EP2662092A1 Method for selecting patient to be given drug for treating septicemia
11/13/2013EP2662090A1 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
11/13/2013EP2662088A2 Anti-connexin compounds and uses thereof
11/13/2013EP2662084A1 Mixture of non-digestible oligosaccharides for stimulating the immune system
11/13/2013EP2662083A1 Sugar compositions for treating hemophilia a and/or von willebrand disease
11/13/2013EP2662082A1 Administration of mTOR inhibitors
11/13/2013EP2662081A1 Therapeutic use of indole-dihydro-imidazole derivatives
11/13/2013EP2662080A1 Nano-diamond conjugate with glycine and method for producing said conjugate
11/13/2013EP2662079A1 Uses of formulations of thyroid hormone antagonists and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells
11/13/2013EP2662078A1 Methods to Treat Allergic Conditions
11/13/2013EP2662077A1 Effervescent compositions containing N-acetylcysteine
11/13/2013EP2662076A1 Oxidation-stabilized tamper-resistant dosage form
11/13/2013EP2662073A1 Octreotide Injection
11/13/2013EP2662072A1 Active ingredient obtained from Cichorium intybus for action on the skin barrier function similar to that of vitamin D
11/13/2013EP2661969A1 Agent for improving milk yield and/or milk quality of ruminants, preventive or therapeutic agent for perinatal disease, and agent for improving reproductive efficiency
11/13/2013EP2661438A2 New bicyclic compound for modulating g protein-coupled receptors
11/13/2013EP2661437A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS
11/13/2013EP2661436A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
11/13/2013EP2661435A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
11/13/2013EP2661434A1 Novel ureas for the treatment and prevention of cancer
11/13/2013EP2661433A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
11/13/2013EP2661432A1 Pyrrolidine derivatives as nk3 antagonists
11/13/2013EP2661431A2 Heterocyclic compounds for the inhibition of pask
11/13/2013EP2661428A1 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
11/13/2013EP2661426A1 Pyrazol-4-yl carboxamide derivatives as microbiocides
11/13/2013EP2661421A2 Nicotinic receptor non-competitive antagonists
11/13/2013EP2661308A1 Hypotonic aqueous composition with reduced chloride content, with or without phospholipids
11/13/2013EP2661275A2 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors
11/13/2013EP2661274A1 Compositions and methods of aloe polysaccharides
11/13/2013EP2661273A2 Pharmaceutical compositions of iron for oral administration
11/13/2013EP2661272A1 Artificial saliva comprising hyaluronic acid
11/13/2013EP2661271A1 Method for manufacturing composition comprising local anesthetic, heparinoid, and buffer
11/13/2013EP2661270A1 Water-soluble dosage forms comprising ibandronate
11/13/2013EP2661269A1 Methods and pharmaceutical compositions for the treatment of ocular inflammatory diseases
11/13/2013EP2661268A2 Inhibitors of polo-like kinase
11/13/2013EP2661267A1 Fused aminodihydrothiazine derivatives
11/13/2013EP2661266A2 Chemosensory receptor ligand-based therapies
11/13/2013EP2661265A1 Quinolines and aza-quinolines as crth2 receptor modulators
11/13/2013EP2661264A1 Melanin modification compositions and methods of use
11/13/2013EP2661263A1 Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy
11/13/2013EP2661262A1 Improved bisphosphonate formulations
11/13/2013EP2661261A1 Immunosuppressant formulations
11/13/2013EP2661260A2 Modified release benzimidazole formulations
11/13/2013EP2661257A1 Effervescent bisphosphonate formulations
11/13/2013EP2661256A1 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
11/13/2013EP2661255A1 Nanotubes as carriers of nucleic acids into cells
11/13/2013EP2661253A1 Liposome formulation suitable for treating or preventing tuberculosis
11/13/2013EP2661252A1 Water soluble dosage forms
11/13/2013EP2661251A1 Method for preparing aqueous pharmaceutical suspensions including a drug that is effective in treating rhinitis
11/13/2013EP2661175A1 Combination steroid and glucocorticoid receptor antagonist therapy
11/13/2013EP2661173A1 Anti-cancer regimen
11/13/2013EP2234485B1 Stable laquinimod preparations
11/13/2013CN1750839B Administration of capsaicinoids
11/13/2013CN103392130A Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
11/13/2013CN103391945A Isoxazolidine derivatives
11/13/2013CN103391944A Novel macrolide intermediate and novel production process
11/13/2013CN103391943A Process for the preparation of phosphoric acid mono- (l-{4- [(s) -5- (acetylaminomethyl) - 2 - oxo - oxazolidin- 3 - yl] - 2, 6 - difluorophenyl} - 4 -methoxymethylpiperidin- 4 - yl) ester
11/13/2013CN103391941A Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
11/13/2013CN103391940A Substituted [(5h-pyrrolo[2,1-c] [1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists
11/13/2013CN103391939A Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
11/13/2013CN103391938A Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses
11/13/2013CN103391937A Compositions and methods for modulating farnesoid x receptors
11/13/2013CN103391936A Anticancer agent
11/13/2013CN103391935A Diaminopyrimidine derivatives and processes for the preparation thereof
11/13/2013CN103391934A Dipyridylamine derivative
11/13/2013CN103391932A Heterocyclic compounds for the inhibition of pask
11/13/2013CN103391931A A method of treating liver fibrosis
11/13/2013CN103391928A 1,4-oxazepines as bace1 and/or bace2 inhibitors
11/13/2013CN103391927A Novel process for preparation of linezolid and its novel intermediates
11/13/2013CN103391924A Novel antiviral compounds
11/13/2013CN103391923A Benzamide derivatives as p2x7 receptor antagonists
11/13/2013CN103391920A Calcium-sensing receptor-active compounds
11/13/2013CN103391783A Methods of using human milk oligosaccharides for improving airway respiratory health
11/13/2013CN103391782A Medicinal agent for prevention or treatment of diseases associated with intraocular neovascularization and/or intraocular vascular hyperpermeability
11/13/2013CN103391780A Combinations of therapeutic agents for use in the treatment of neurodegenerative diseases
11/13/2013CN103391779A Prostate cancer therapy with HSP90 inhibitory compounds
11/13/2013CN103391778A Pharmaceutical compositions
11/13/2013CN103391777A Sirtuin modulators as virus production modulators
1 ... 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 ... 7860